Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
34.3M
-
Shares change
-
+1.76M
-
Total reported value, excl. options
-
$129M
-
Value change
-
+$5.43M
-
Put/Call ratio
-
0
-
Number of buys
-
51
-
Number of sells
-
-34
-
Price
-
$3.76
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q3 2015
104 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q3 2015.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.3M shares
of 106M outstanding shares and own 32.36% of the company stock.
Largest 10 shareholders include FEDERATED INVESTORS INC /PA/ (14.2M shares), VANGUARD GROUP INC (2.7M shares), BlackRock Institutional Trust Company, N.A. (2.47M shares), MORGAN STANLEY (2.15M shares), INVESTOR AB (1.83M shares), BlackRock Fund Advisors (1.62M shares), STATE STREET CORP (852K shares), NORTHERN TRUST CORP (677K shares), GEODE CAPITAL MANAGEMENT, LLC (484K shares), and RENAISSANCE TECHNOLOGIES LLC (452K shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.